- Beeline ups its Series A round for immune drug work<figure><div><img src="https://imgproxy.divecdn.com/4FSYxYVR65mzzE0lNMMPQjdujTL0_B50-03lC1bSrS8/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS8yWEtHQ0JZLmpwZw==.webp"/></div></f…BioPharma Dive · 28d ago↗ source
- Top FDA gene and cell therapy regulator to step down<figure><div><img src="https://imgproxy.divecdn.com/ZralPibwV2FS7gfl92V7anvyG-GCm_2yJ_lZgP4LM4k/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS8yRENKUkI1LmpwZw==.webp"/></div></f…BioPharma Dive · 28d ago↗ source
- Nominations are open for the 2026 Endpoints 11 awardsThere’s never been a higher bar for innovation than right now. Almost any promising molecule quickly has a horde of copycats. Development costs keep rising. Investors are leaning on seemingly saf…